Replies to post #105024 on Avid Bioservices Inc (CDMO)

[freethemice]

We know that the control arm for the bavi+ doc second-line NSCLC has a MOS of 5.6 months. I don't see a parallel to this BLP25 trial.

[freethemice]

I don't consider that as a "misspost" but rather your lack of doing any checking of the facts.

[nuke661]

Exwannabe,

I understand now that you were trying to make a point.

[Robert C Jonson]

And their math was about right IF the comparator arm had come in as expected.

Ex, please forgive me if this is a stupid question, but was the ONTY trial a failure because the control arm patients lived basically (i.e., no significant difference) as long as the treatment arm did?

Thanks.